首页 › 基金 › Portman Square Capital LLP › ENOV
Portman Square Capital LLP 对 ENOV 的持仓历史
ENOVIS CORPORATION · 医疗保健
Portman Square Capital LLP 在 Q3 2026 的 13F 申报中披露持有 ENOV(ENOVIS CORPORATION)553,000 股,市值约 US$10.1M,约占其申报组合的 1.01%,在其申报持仓中市值排名第 19 位。 Portman Square Capital LLP 最近 12 个申报季度中有 12 个季度披露了 ENOV 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-10-15 · 来源: SEC EDGAR Form 13F-HR
Portman Square Capital LLP 对 ENOV 的持仓演变
Portman Square Capital LLP 于 Q4 2023 首次披露 ENOV 持仓:375,700 股(约 US$21.0M)。 该持仓在 Q1 2024 达到峰值 375,700 股,市值约 US$23.5M。 在 12 次申报中,Portman Square Capital LLP 4 次增持、5 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 553,000 股、市值约 US$10.1M,环比减持 -10,800 股。。 持仓曾出现大幅变动:Q3 2024 增持约 3688% (随后一个季度股价上涨 2%)、Q4 2025 增持约 192% (随后一个季度股价下跌 15%)、Q1 2026 增持约 100% (随后一个季度股价下跌 9%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 375.70K | $21.05M | 新进 |
| Q1 2024 | 375.70K | $23.46M | 持有 |
| Q2 2024 | 10.68K | $482.87K | 减持 |
| Q3 2024 | 404.70K | $17.42M | 增持 |
| Q4 2024 | 404.70K | $17.76M | 持有 |
| Q1 2025 | 290.20K | $11.09M | 减持 |
| Q2 2025 | 372.50K | $11.68M | 增持 |
| Q3 2025 | 170.40K | $5.17M | 减持 |
| Q4 2025 | 498.30K | $13.27M | 增持 |
| Q1 2026 | 998.60K | $22.72M | 增持 |
| Q2 2026 | 563.80K | $11.67M | 减持 |
| Q3 2026 | 553.00K | $10.10M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ENOV 与 13F 数据
ENOV(ENOVIS CORPORATION)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 ENOV,申报仓位最大的包括:Rubric Capital Management LP (US$80.7M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PARADIGM CAPITAL MANAGEMENT INC/NY (US$28.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ENOV 的基金
- Rubric Capital Management LP 3.90M 股 · $80.73M · Q2 2026
- OAKTREE CAPITAL MANAGEMENT LP 39.21M 股 · $37.79M · Q2 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 1.38M 股 · $28.53M · Q2 2026
更多关于 Portman Square Capital LLP
常见问题
How long has Portman Square Capital LLP held ENOV?
Portman Square Capital LLP has disclosed ENOV holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Portman Square Capital LLP's current position in ENOV?
As of Q3 2026, Portman Square Capital LLP holds 553.00K shares of ENOV (ENOVIS CORPORATION), valued at $10.10M, representing 1.01% of its reported portfolio and ranking #19.
Has Portman Square Capital LLP been buying or selling ENOV?
In the latest 13F filing (Q3 2026), Portman Square Capital LLP reduced its position in ENOV. The position peaked in Q1 2024 at 375.70K shares.
Which other funds hold ENOV?
Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PARADIGM CAPITAL MANAGEMENT INC/NY, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.